We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLAU icon
7001
Franklin FTSE Australia ETF
FLAU
$182M
$32K ﹤0.01%
1,111
-880
-44% -$25.2K
CSSE
7002
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$32K ﹤0.01%
164,800
+162,401
+6,770% +$41.6K
PHUN icon
7003
Phunware
PHUN
$44.6M
$32K ﹤0.01%
5,821
+5,670
+3,755% +$37.3K
VALQ icon
7004
American Century US Quality Value ETF
VALQ
$337M
$31.9K ﹤0.01%
563
-438
-44% -$24.7K
XJUL icon
7005
FT Vest US Equity Enhance & Moderate Buffer ETF July
XJUL
$42.4M
$31.9K ﹤0.01%
941
-58
-6% -$1.94K
IVA
7006
Inventiva
IVA
$1.1B
$31.8K ﹤0.01%
10,649
+10,507
+7,399% +$35.7K
ENGN icon
7007
enGene Therapeutics
ENGN
$121M
$31.8K ﹤0.01%
+3,370
New +$43.2K
EDZ icon
7008
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$18.4M
$31.8K ﹤0.01%
342
+256
+298% +$25.3K
SKYH icon
7009
Sky Harbour Group
SKYH
$382M
$31.7K ﹤0.01%
+3,431
New +$35.7K
KGRN icon
7010
KraneShares MSCI China Clean Technology Index ETF
KGRN
$53.6M
$31.7K ﹤0.01%
1,614
-877
-35% -$18K
PWOD
7011
DELISTED
Penns Woods Bancorp
PWOD
$31.7K ﹤0.01%
1,543
-5,786
-79% -$111K
DSEP icon
7012
FT Vest US Equity Deep Buffer ETF September
DSEP
$354M
$31.6K ﹤0.01%
808
-213
-21% -$8.19K
SEIV icon
7013
SEI QiM U.S. Large Cap Value Active ETF
SEIV
$1.49B
$31.4K ﹤0.01%
+1,008
New +$30.7K
CSTE icon
7014
Caesarstone
CSTE
$76.1M
$31.4K ﹤0.01%
6,271
-47,146
-88% -$267K
ORBS
7015
Eightco Holdings
ORBS
$259M
$31.3K ﹤0.01%
13,657
+11,762
+621% +$36.5K
GLSI icon
7016
Greenwich LifeSciences
GLSI
$209M
$31.2K ﹤0.01%
1,807
+1,405
+350% +$20.5K
NPCE icon
7017
Neuropace
NPCE
$474M
$31K ﹤0.01%
4,104
+2,404
+141% +$24.3K
ABXB
7018
Abacus Flexible Bond Leaders ETF
ABXB
$1.91M
$31K ﹤0.01%
1,489
+1,475
+10,536% +$30.8K
UAPR icon
7019
Innovator US Equity Ultra Buffer ETF April
UAPR
$158M
$31K ﹤0.01%
+1,066
New +$30.1K
ABOS icon
7020
Acumen Pharmaceuticals
ABOS
$165M
$30.9K ﹤0.01%
12,786
+6,143
+92% +$19.6K
PRTH icon
7021
Priority Technology Holdings
PRTH
$443M
$30.9K ﹤0.01%
5,849
-12,035
-67% -$45.5K
AACI
7022
DELISTED
Armada Acquisition Corp. I Common Stock
AACI
$30.8K ﹤0.01%
2,690
+2,592
+2,645% +$29.6K
IDAI icon
7023
T Stamp
IDAI
$17.5M
$30.6K ﹤0.01%
+4,392
New +$47.2K
NRGV icon
7024
Energy Vault
NRGV
$536M
$30.6K ﹤0.01%
32,179
-101,825
-76% -$126K
SGMO
7025
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$30.5K ﹤0.01%
85,214
-75,086
-47% -$40.6K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.